Regulatory analysis on the medical use of ephedrine-related products in Taiwan

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.
原文英語
期刊Journal of Food and Drug Analysis
26
發行號2
DOIs
出版狀態已發佈 - 四月 2018

指紋

ephedrine
Ephedrine
Taiwan
police
drugs
Police
Pharmaceutical Preparations
Health
amphetamine
Government Agencies
government agencies
supply balance
Amphetamine
United States Food and Drug Administration
control methods
Japan
manufacturing

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

引用此文

@article{ec437b9d99454c8ab458766ad644f2e6,
title = "Regulatory analysis on the medical use of ephedrine-related products in Taiwan",
abstract = "To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.",
keywords = "Controlled Drugs Act, Ephedrine-related products, Pharmaceutical Affairs Act, Pharmacists Act, Taiwan Food and Drug Administration (TFDA)",
author = "Yu, {Wan Nan} and Wang, {Li Hsuan} and Cheng, {Hui Wen}",
year = "2018",
month = "4",
doi = "10.1016/j.jfda.2017.11.002",
language = "English",
volume = "26",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Regulatory analysis on the medical use of ephedrine-related products in Taiwan

AU - Yu, Wan Nan

AU - Wang, Li Hsuan

AU - Cheng, Hui Wen

PY - 2018/4

Y1 - 2018/4

N2 - To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.

AB - To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.

KW - Controlled Drugs Act

KW - Ephedrine-related products

KW - Pharmaceutical Affairs Act

KW - Pharmacists Act

KW - Taiwan Food and Drug Administration (TFDA)

UR - http://www.scopus.com/inward/record.url?scp=85036636130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036636130&partnerID=8YFLogxK

U2 - 10.1016/j.jfda.2017.11.002

DO - 10.1016/j.jfda.2017.11.002

M3 - Article

AN - SCOPUS:85036636130

VL - 26

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 2

ER -